KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Operating Margin: 2011-2025

Historic Operating Margin for TherapeuticsMD (TXMD) over the last 15 years, with Sep 2025 value amounting to -109.95%.

  • TherapeuticsMD's Operating Margin rose 9736.00% to -109.95% in Q3 2025 from the same period last year, while for Sep 2025 it was -61.80%, marking a year-over-year increase of 35649.00%. This contributed to the annual value of -270.30% for FY2024, which is 38431.00% up from last year.
  • Latest data reveals that TherapeuticsMD reported Operating Margin of -109.95% as of Q3 2025, which was down 50.61% from -73.00% recorded in Q2 2025.
  • TherapeuticsMD's 5-year Operating Margin high stood at 104.95% for Q4 2024, and its period low was -4,269.25% during Q2 2022.
  • Its 3-year average for Operating Margin is -630.61%, with a median of -320.92% in 2023.
  • Its Operating Margin has fluctuated over the past 5 years, first tumbled by 411,631bps in 2022, then soared by 370,358bps in 2023.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Operating Margin stood at -189.48% in 2021, then skyrocketed by 26,014bps to 70.65% in 2022, then plummeted by 39,157bps to -320.92% in 2023, then skyrocketed by 42,586bps to 104.95% in 2024, then skyrocketed by 9,736bps to -109.95% in 2025.
  • Its Operating Margin was -109.95% in Q3 2025, compared to -73.00% in Q2 2025 and -221.63% in Q1 2025.